Abstract
Several lines of evidence suggest that aberrant Notch signaling contributes to the development of several types of cancer. Activation of Notch receptor is executed through intramembrane proteolysis by γ-secretase, which is a multimeric membrane-embedded protease comprised of presenilin, nicastrin (NCT), anterior pharynx defective 1 and PEN-2. In this study, we report the neutralization of the γ-secretase activity by a novel monoclonal antibody A5226A against the extracellular domain of NCT, generated by using a recombinant budded baculovirus as an immunogen. This antibody recognized fully glycosylated mature NCT in the active γ-secretase complex on the cell surface, and inhibited the γ-secretase activity by competing with the substrate binding in vitro. Moreover, A5226A abolished the γ-secretase activity-dependent growth of cancer cells in a xenograft model. Our data provide compelling evidence that NCT is a molecular target for the mechanism-based inhibition of γ-secretase, and that targeting NCT might be a novel therapeutic strategy against cancer caused by aberrant γ-secretase activity and Notch signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boesze-Battaglia K . (2006). Isolation of membrane rafts and signaling complexes. Methods Mol Biol 332: 169–179.
Chavez-Gutierrez L, Tolia A, Maes E, Li T, Wong PC, de Strooper B . (2008). Glu(332) in the Nicastrin ectodomain is essential for γ-secretase complex maturation but not for its activity. J Biol Chem 283: 20096–20105.
De Strooper B, Vassar R, Golde T . (2010). The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6: 99–107.
Dries DR, Shah S, Han YH, Yu C, Yu S, Shearman MS et al. (2009). Glu-333 of nicastrin directly participates in γ-secretase activity. J Biol Chem 284: 29714–29724.
Dunn CD, Sulis ML, Ferrando AA, Greenwald I . (2010). A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells. Proc Natl Acad Sci USA 107: 5907–5912.
Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ et al. (2002). Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate. Proc Natl Acad Sci USA 99: 2720–2725.
Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM et al. (2006). Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66: 7445–7452.
Ferrando AA . (2009). The role of NOTCH1 signaling in T-ALL. Hematology (Am Soc Hematol Educ Program) 2009: 353–361.
Filipovic A, Gronau JH, Green AR, Wang J, Vallath S, Shao D et al. (2011). Biological and clinical implications of nicastrin expression in invasive breast cancer. Breast Cancer Res Treat 125: 43–53.
Hayashi I, Takatori S, Urano Y, Iwanari H, Isoo N, Osawa S et al. (2009). Single chain variable fragment against nicastrin inhibits the γ-secretase activity. J Biol Chem 284: 27838–27847.
Hayashi I, Urano Y, Fukuda R, Isoo N, Kodama T, Hamakubo T et al. (2004). Selective reconstitution and recovery of functional γ-secretase complex on budded baculovirus particles. J Biol Chem 279: 38040–38046.
Imamura Y, Watanabe N, Umezawa N, Iwatsubo T, Kato N, Tomita T et al. (2009). Inhibition of γ-secretase activity by helical β-peptide foldamers. J Am Chem Soc 131: 7353–7359.
Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A et al. (2002). Presenilin-1 affects trafficking and processing of βAPP and is targeted in a complex with nicastrin to the plasma membrane. J Cell Biol 158: 551–561.
Kimura K, Satoh K, Kanno A, Hamada S, Hirota M, Endoh M et al. (2007). Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Sci 98: 155–162.
Kopan R, Ilagan MX . (2009). The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216–233.
Lawrence CM, Ray S, Babyonyshev M, Galluser R, Borhani DW, Harrison SC . (1999). Crystal structure of the ectodomain of human transferrin receptor. Science 286: 779–782.
LaVoie MJ, Fraering PC, Ostaszewski BL, Ye W, Kimberly WT, Wolfe MS et al. (2003). Assembly of the γ-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin. J Biol Chem 278: 37213–37222.
Li T, Ma G, Cai H, Price DL, Wong PC . (2003). Nicastrin is required for assembly of presenilin/γ-secretase complexes to mediate Notch signaling and for processing and trafficking of β-amyloid precursor protein in mammals. J Neurosci 23: 3272–3277.
Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D et al. (2009). Preclinical profile of a potent γ-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res 69: 7672–7680.
Masuda K, Itoh H, Sakihama T, Akiyama C, Takahashi K, Fukuda R et al. (2003). A combinatorial G protein-coupled receptor reconstitution system on budded baculovirus. Evidence for Galpha and Galphao coupling to a human leukotriene B4 receptor. J Biol Chem 278: 24552–24562.
Masuda S, Kumano K, Suzuki T, Tomita T, Iwatsubo T, Natsugari H et al. (2009). Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model. Cancer Sci 100: 2444–2450.
Osipo C, Patel P, Rizzo P, Clementz AG, Hao L, Golde TE et al. (2008). ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor. Oncogene 27: 5019–5032.
Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B et al. (2010). Targeting Notch to target cancer stem cells. Clin Cancer Res 16: 3141–3152.
Saitoh R, Ohtomo T, Ito Y, Nezu J, Kimura N, Funahashi S et al. (2006). Recovery of functional peptide transporter PepT1 in budded baculovirus fraction. Protein Expr Purif 46: 130–135.
Saitoh R, Ohtomo T, Yamada Y, Kamada N, Nezu J, Kimura N et al. (2007). Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus. J Immunol Methods 322: 104–117.
Samaranayake H, Wirth T, Schenkwein D, Raty JK, Yla-Herttuala S . (2009). Challenges in monoclonal antibody-based therapies. Ann Med 41: 322–331.
Shah S, Lee SF, Tabuchi K, Hao YH, Yu C, LaPlant Q et al. (2005). Nicastrin functions as a γ-secretase-substrate receptor. Cell 122: 435–447.
Shirotani K, Edbauer D, Capell A, Schmitz J, Steiner H, Haass C . (2003). γ-secretase activity is associated with a conformational change of nicastrin. J Biol Chem 278: 16474–16477.
Shirotani K, Edbauer D, Kostka M, Steiner H, Haass C . (2004). Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1. J Neurochem 89: 1520–1527.
Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y et al. (2003). The role of presenilin cofactors in the γ-secretase complex. Nature 422: 438–441.
Takahashi Y, Hayashi I, Tominari Y, Rikimaru K, Morohashi Y, Kan T et al. (2003). Sulindac sulfide is a noncompetitive γ-secretase inhibitor that preferentially reduces Aβ42 generation. J Biol Chem 278: 18664–18670.
Tarassishin L, Yin YI, Bassit B, Li YM . (2004). Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct. Proc Natl Acad Sci USA 101: 17050–17055.
Tomita T, Katayama R, Takikawa R, Iwatsubo T . (2002). Complex N-glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments. FEBS Lett 520: 117–121.
Tomita T . (2009). Secretase inhibitors and modulators for Alzheimer′s disease treatment. Expert Rev Neurother 9: 661–679.
Urano Y, Hayashi I, Isoo N, Reid PC, Shibasaki Y, Noguchi N et al. (2005). Association of active γ-secretase complex with lipid rafts. J Lipid Res 46: 904–912.
Urano Y, Yamaguchi M, Fukuda R, Masuda K, Takahashi K, Uchiyama Y et al. (2003). A novel method for viral display of ER membrane proteins on budded baculovirus. Biochem Biophys Res Commun 308: 191–196.
Vetrivel KS, Thinakaran G . (2010). Membrane rafts in Alzheimer's disease β-amyloid production. Biochim Biophys Acta 1801: 860–867.
Wakabayashi T, Craessaerts K, Bammens L, Bentahir M, Borgions F, Herdewijn P et al. (2009). Analysis of the γ-secretase interactome and validation of its association with tetraspanin-enriched microdomains. Nat Cell Biol 11: 1340–1346.
Weiner LM, Surana R, Wang S . (2010). Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol 10: 317–327.
Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269–271.
Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y et al. (2010). Therapeutic antibody targeting of individual Notch receptors. Nature 464: 1052–1057.
Yin L, Velazquez OC, Liu ZJ . (2010). Notch signaling: emerging molecular targets for cancer therapy. Biochem Pharmacol 80: 690–701.
Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A et al. (2000). Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 407: 48–54.
van Es JH, Clevers H . (2005). Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 11: 496–502.
van Tetering G, van Diest P, Verlaan I, van der Wall E, Kopan R, Vooijs M . (2009). Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem 284: 31018–31027.
Zhao G, Liu Z, Ilagan MX, Kopan R . (2010). γ-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrin. J Neurosci 30: 1648–1656.
Acknowledgements
We are grateful to Drs T Fukuyama, S Yokoshima (The University of Tokyo), C Haass (Ludwig-Maximilians-University München), H Natsugari (Teikyo University), R Kopan (Washington University in St Louis), G Thinakaran (The University of Chicago), M Vooijs (University Medical Center Utrecht Cancer Center) and G Yu (The University of Texas Southwestern Medical Center) for valuable reagents and our current and previous laboratory members for helpful discussions. We also would like to thank Keiko Tamura-Kawakami and Maiko Nampo for their excellent technical support. This work is supported in part by Grants-in-Aid for Young Scientists (S) (for TT) from Japan Society for the Promotion of Science (JSPS), by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (for TT, TI), Scientific Research on Priority Areas ‘Research on Pathomechanisms of Brain Disorders’ from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (for TT, TI), by Targeted Proteins Research Program grant from the MEXT (for TT, TI, JT), by Core Research for Evolutional Science and Technology grant from the MEXT (for TT, TI), Japan. IH and ST were research fellows of JSPS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Hayashi, I., Takatori, S., Urano, Y. et al. Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin. Oncogene 31, 787–798 (2012). https://doi.org/10.1038/onc.2011.265
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.265
Keywords
This article is cited by
-
High-efficient production and biophysical characterisation of nicastrin and its interaction with APPC100
Scientific Reports (2017)
-
Targeting of proangiogenic signalling pathways in chronic inflammation
Nature Reviews Rheumatology (2016)
-
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells
Breast Cancer Research (2014)
-
Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase
Nature Communications (2014)
-
The role of genes co-amplified with nicastrin in breast invasive carcinoma
Breast Cancer Research and Treatment (2014)